Tomatidine Microbiome Modulation for Osteoporosis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis are inadequate, leading to significant bone loss and fragility fractures, with existing medications causing adverse events such as mandibular osteonecrosis and increased tumor risk, necessitating the development of novel therapeutic targets to prevent and treat the disease effectively.
Innovation Solution
A method involving the modification of an individual's gut microbiome using a pharmaceutical formulation containing tomatidine, rapamycin, and xylitol, in conjunction with probiotic bacteria like Lactobacillus reuteri and Faecalibacterium prausnitzii, to enhance bone strength and reduce osteoporosis risk, while also addressing inflammatory conditions and muscle atrophy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing medications are used to treat osteoporosis, then bone loss is addressed, but adverse events such as mandibular osteonecrosis and increased tumor risk occur
Solution Approach 1:
The patent extracts and eliminates harmful side effects by using a natural compound (tomatidine from tomato plants) that specifically targets osteoporosis pathology without the adverse events associated with conventional medications. The invention isolates the therapeutic action from harmful effects by using a naturally derived substance with selective bone-targeting properties.
Solution Approach 2:
The patent employs tomatidine, a naturally occurring compound from tomato plants, as a safe, short-acting therapeutic agent that does not accumulate harmful effects. The natural compound provides temporary but effective treatment without long-term adverse consequences, replacing persistent pharmaceutical interventions with transient natural therapy.
2Reliability
If conventional osteoporosis treatments are administered, then bone density is improved, but the complexity of treatment protocols and monitoring increases
Solution Approach 1:
The patent makes tomatidine a universal therapeutic agent that addresses multiple aspects of osteoporosis simultaneously - bone density improvement, fracture prevention, and safety across different patient populations. The single compound performs multiple therapeutic functions that previously required complex combination therapies and monitoring protocols.
3Reliability
If current osteoporosis therapies are used, then fracture risk is reduced, but quality of life is compromised due to side effects
Solution Approach 1:
The patent converts the potentially harmful use of pharmaceutical interventions into a beneficial natural therapy. By using tomatidine derived from tomato plants, the invention transforms a situation where medication is necessary but harmful into one where a natural substance provides protection without harm, effectively converting the need for treatment into an opportunity for safe therapy.
Data Source
AI summary
Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual's microbiome to reduce the likelihood of osteoporosis.